Northern Trust’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Northern Trust’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-885	Closed	-$7.01K	–	4485
2024 Q1	$7.01K	Hold	885	–	–	﹤0.01%	4402
2023 Q4	$6.36K	Hold	885	–	–	﹤0.01%	4448
2023 Q3	$16.6K	Hold	885	–	–	﹤0.01%	4357
2023 Q2	$25.2K	Hold	885	–	–	﹤0.01%	4361
2023 Q1	$49.4K	Hold	885	–	–	﹤0.01%	4274
2022 Q4	$19.1K	Hold	885	–	–	﹤0.01%	4496
2022 Q3	$26K	Hold	885	–	–	﹤0.01%	4503
2022 Q2	$29K	Sell	885 -3,082	-78%	-$213K	﹤0.01%	4564
2022 Q1	$383K	Buy	3,967 +244	+7%	+$37K	﹤0.01%	3842
2021 Q4	$723K	Buy	3,723 +258	+7%	+$40.2K	﹤0.01%	3667
2021 Q3	$694K	Buy	+3,465	New	+$879K	﹤0.01%	3652

Other funds holding TBIO

Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DWS

Dynamic Wealth Strategies Granite Bay, California $188M AUM 18.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Northern Trust's TBIO Position: Q2 2024 in Review

Northern Trust sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q2 2024, closing a stake of 885 shares — an estimated $7.01K sold.

Northern Trust first reported a position in TBIO in Q3 2021 and held it in 11 quarters. The position peaked at $723K in Q4 2021. 10 funds tracked by Wall St. Rank hold TBIO as of Q2 2024.

Northern Trust reported no remaining Telesis Bio, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Northern Trust sold 885 Telesis Bio, Inc. Common Stock shares in Q2 2024, an estimated $7.01K.
Northern Trust first reported a position in Telesis Bio, Inc. Common Stock in Q3 2021 and held it in 11 quarters.
Northern Trust's Telesis Bio, Inc. Common Stock position peaked at $723K in Q4 2021.
10 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q2 2024.

Based on Northern Trust's 13F filing for Q2 2024, filed 14 Aug 2024.